Skip to main content
OpenTrials

Clinical trial condition

Central Nervous System Diseases

Explore clinical trials studying Central Nervous System Diseases. Study availability and eligibility vary by location and protocol.

30,346 public trials 5,677 recruiting studies
Refine in advanced search Browse all conditions

Central Nervous System Diseases trial results

Completed

To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

NCT00141245

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +3 more
Locations
  • Pfizer Investigational Site Deakin, Australian Capital Territory, Australia
  • Pfizer Investigational Site Chatswood, New South Wales, Australia
  • Pfizer Investigational Site Westmead, New South Wales, Australia
  • Pfizer Investigational Site Maroochydore, Queensland, Australia
View all 46 locations
View Trial Details
Completed

To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.

NCT00141414

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +3 more
Locations
  • Pfizer Investigational Site Little Rock, Arkansas, United States
  • Pfizer Investigational Site Los Angeles, California, United States
  • Pfizer Investigational Site Stanford, California, United States
  • Pfizer Investigational Site Miami, Florida, United States
View all 25 locations
View Trial Details
Completed

To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

NCT00141336

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +3 more
Locations
  • Pfizer Investigational Site Phoenix, Arizona, United States
  • Pfizer Investigational Site Tucson, Arizona, United States
  • Pfizer Investigational Site Bakersfield, California, United States
  • Pfizer Investigational Site Berkeley, California, United States
View all 103 locations
View Trial Details
Completed

Study of an Extended-Release, Crystalline Formulation of Recombinant Human Growth Hormone (ALTU-238) in Growth Hormone Deficient Adults to Determine Pharmacokinetics, Pharmacodynamics, and Drug Safety

NCT00297713

Conditions
Adult Growth Hormone Deficiency, Bone Diseases, Bone Diseases, Developmental, +11 more
Locations
  • University of Louisville Louisville, Kentucky, United States
  • University of Texas Medical Branch Galveston, Texas, United States
  • Diabetes and Glandular Disease Clinic San Antonio, Texas, United States
View Trial Details

Related conditions